(Q41769462)

English

Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype

scientific article published on January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

1 reference

based on heuristic

inferred from title

author name string

E A Grimm

1

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

J M Bruner

2

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

J Carinhas

3

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

J A Köppen

4

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

W G Loudon

5

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

L Owen-Schaub

6

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

P A Steck

7

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

R P Moser

8

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

391-399

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of natural killer cells via the p75 interleukin 2 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and in vitro growth of glioma-infiltrating lymphocytes, and an analysis of their surface phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltration in gliomas: evidence of possible host resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of lymphocyte invasion and survival of brain tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of lymphoid cells isolated from human gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1848799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01741334

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41769462&oldid=2204763316"